New Infant Cereal
Dietary SupplementNew Infant Cereal
NCT Number: NCT02165956
The purpose of this study is to determine whether a new infant cereal has an effect on weight gain and intestinal microbiota compared to a standard cereal in healthy infants .
Looking for future studies?
Notify Me6 month–6 month
All sexes
Interventional
Not applicable
Consultorio de Soto de la Marina, Soto de la Marina, Cantabria, Spain
This is a multicenter, controlled, randomized, prospective, parallel-group, double-blind study to evaluate the effect of a new infant cereal supplemented with prebiotics, probiotics, vegetable proteins and a special blend of starches on weight gain and intestinal microbiota in healthy infants from 6 to 12 moths of age. Patients will be randomized to receive either the new infant cereal or a standard cereal.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
New Infant Cereal
Standard Infant Cereal
Time frame: At 6, 9, 12, 15 and 18 months of age
Difference between groups measured by a composite of nutritional parameters(weight, height, perimeters and skin fold measurements).
Time frame: At 6, 9, 12, 15 and 18 months of age
Differences between groups measured by a 3-day food record.
Time frame: At 6, 9, 12, 15 and 18 months of age
Differences between groups measured by frequency and type of a composite of gastrointestinal symptoms (regurgitation, irritability, flatulence and crying).
Time frame: At 6, 9, 12 and 18 months of age
Differences between groups measured by the analysis of faecal samples.
Laboratorios Ordesa
Industry
Effect of a New Food Product on Weight Gain During First Infancy
Acronym: CEOBE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04454645
Chemically-Induced Disorders, Infant Development
Newark, Delaware, United States
View Trial DetailsNCT06053515
Depression, Postpartum, Depressive Disorder
College Park, Maryland, United States
View Trial DetailsNCT05793112
Food Protein Induced Allergic Proctocolitis, Gut Microbiome
Newton, Massachusetts, United States
View Trial DetailsNCT06230848
Infant Development, Stress
Maywood, Illinois, United States
View Trial Details